| EIM | UC Frequency | Crohn's Frequency | Activity Correlation | HLA Association |
|---|---|---|---|---|
| Erythema nodosum | 2–4% | 2–4% | Yes (active disease) | — |
| Pyoderma gangrenosum | 0.5–2% | 0.5–2% | Variable | — |
| Primary sclerosing cholangitis | 1–4% | <1% | No (independent) | — |
| Ankylosing spondylitis | 1–3% | 1–3% | No | HLA-B27 |
| Peripheral arthritis | 4–6% | 4–6% | Yes (active disease) | — |
| Uveitis | 0.5–1% | 0.5–1% | Variable | — |
Option 1 (Erythema nodosum): ✓ Correct — Occurs in 2–4% of UC patients; presents as painful, tender nodules on the shins and ankles; correlates with disease activity and typically resolves with treatment of the underlying IBD.
Option 2 (Primary sclerosing cholangitis): ✓ Correct — Associated with UC in 1–4% of cases; crucially, PSC may progress independently of bowel disease activity and may even develop or worsen after colectomy. This is a key distinguishing feature from other EIMs.
Option 3 (Ankylosing spondylitis): ✓ Correct — Occurs in 1–3% of UC patients; HLA-B27 positive in the majority (70–90%); does not correlate with bowel disease activity.
Option 4 (Pyoderma gangrenosum): ✗ WRONG — This option claims pyoderma gangrenosum is pathognomonic for ulcerative colitis and never occurs in Crohn's disease. This is factually incorrect. Pyoderma gangrenosum occurs in both UC (0.5–2%) and Crohn's disease (0.5–2%) with similar frequency. It is not pathognomonic for either disease and can also occur in other systemic conditions (rheumatoid arthritis, malignancy, etc.).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →